Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Clayburgh

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
The Laryngoscope|June 8, 2012
Progression and management of Wegener's granulomatosis in the head and neckStanford C Taylor, Daniel R Clayburgh, James T Rosenbaum, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 13, 2006
Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel diseaseStephanie A Blair, Sunanda V Kane, Daniel R Clayburgh, et al.
Journal of Oncology|November 16, 2010
Cancer stem cells in head and neck squamous cell carcinomaMarcus M Monroe, Eric C Anderson, Daniel R Clayburgh, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 19, 2013
Clinical manifestations and treatment of idiopathic and Wegener granulomatosis-associated subglottic stenosisStanford C Taylor, Daniel R Clayburgh, James T Rosenbaum, et al.
Head & Neck|October 6, 2012
Factors associated with supracricoid laryngectomy functional outcomesDaniel R Clayburgh, Donna J Graville, Andrew D Palmer, et al.
Head & Neck|April 13, 2012
Effects of epidermal growth factor receptor and insulin-like growth factor 1 receptor inhibition on proliferation and intracellular signaling in cutaneous SCCHN: potential for dual inhibition as a therapeutic modalityDaniel R Clayburgh, Neil D Gross, Charlotte Proby, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 30, 2005
Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivoDonnie E Shifflett, Daniel R Clayburgh, Athanasia Koutsouris, et al.
The Journal of Clinical Investigation|October 4, 2006
Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivoDaniel R Clayburgh, Mark W Musch, Michael Leitges, et al.
The New England Journal of Medicine|September 5, 2008
Clinical problem-solving. Collateral damageDaniel R Clayburgh, John D Yoon, Nicole A Cipriani, et al.
The Laryngoscope|November 24, 2011
Airway reconstruction in Wegener's granulomatosis-associated laryngotracheal stenosisJacob L Wester, Daniel R Clayburgh, William J Stott, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The Laryngoscope|June 8, 2012
Progression and management of Wegener's granulomatosis in the head and neckStanford C Taylor, Daniel R Clayburgh, James T Rosenbaum, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 13, 2006
Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel diseaseStephanie A Blair, Sunanda V Kane, Daniel R Clayburgh, et al.
Journal of Oncology|November 16, 2010
Cancer stem cells in head and neck squamous cell carcinomaMarcus M Monroe, Eric C Anderson, Daniel R Clayburgh, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 19, 2013
Clinical manifestations and treatment of idiopathic and Wegener granulomatosis-associated subglottic stenosisStanford C Taylor, Daniel R Clayburgh, James T Rosenbaum, et al.
Head & Neck|October 6, 2012
Factors associated with supracricoid laryngectomy functional outcomesDaniel R Clayburgh, Donna J Graville, Andrew D Palmer, et al.
Head & Neck|April 13, 2012
Effects of epidermal growth factor receptor and insulin-like growth factor 1 receptor inhibition on proliferation and intracellular signaling in cutaneous SCCHN: potential for dual inhibition as a therapeutic modalityDaniel R Clayburgh, Neil D Gross, Charlotte Proby, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 30, 2005
Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivoDonnie E Shifflett, Daniel R Clayburgh, Athanasia Koutsouris, et al.
The Journal of Clinical Investigation|October 4, 2006
Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivoDaniel R Clayburgh, Mark W Musch, Michael Leitges, et al.
The New England Journal of Medicine|September 5, 2008
Clinical problem-solving. Collateral damageDaniel R Clayburgh, John D Yoon, Nicole A Cipriani, et al.
The Laryngoscope|November 24, 2011
Airway reconstruction in Wegener's granulomatosis-associated laryngotracheal stenosisJacob L Wester, Daniel R Clayburgh, William J Stott, et al.
Pageof 5